Kumararatne D S
Regional Immunology Department, Birmingham Heartlands Hospital.
Hosp Med. 1998 Dec;59(12):936-7.
Bio Products Laboratory (BPL), the main fractionator of plasma-derived medicines, are undergoing a change from UK plasma to plasma from the USA. BPL aim to maintain continuity of supply and a seamless changeover, despite meticulous cleaning of its production plant and months of auditing by both the organization and regulatory authorities.
